SMMT
Summit Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.61
+2.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 432.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 22.29x
- Price / sales
- —
- Price / cash flow
- -34.65x
Enterprise value
- Enterprise value
- $13.4B
- EV / sales
- —
- EV / EBITDA
- -15.63x
- EV / EBIT
- -15.29x
- Market cap
- $14.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026